Clever Culture Systems, an Australian-based company focused on environmental monitoring, has reported continued progress for its APAS Independence platform in the first half of fiscal year 2026.
The report highlights the company’s expanding global footprint and strategic focus on major pharmaceutical customers.
What global growth does the report show?
During the period, four new APAS Independence orders were confirmed, bringing the total installed base to 27 units globally, excluding instruments currently leased or under evaluation.
Notable new placements were made with global pharmaceutical manufacturers Novo Nordisk and Boehringer Ingelheim, who are now evaluating the system for broader deployment across their manufacturing networks.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cleanroom Technology.
Subscribe now Already a subscriber? Sign in here.